Vancouver, BC — October 15, 2025 — Telescope Innovations Corp. (CSE:TELI) (OTCQB:TELIF) (FSE:J4U) (the “Company”), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries announces that it has authorized the grant of incentive stock options and approved the cancellation of certain previously issued options under its stock option plan, as well as the issuance of common shares to settle outstanding fees owed to directors.
Stock Option Grants and Cancellations
The Company has granted 1,544,000 incentive stock options (the “Options”) to certain directors, employees and consultants. The Options will vest over a period of three-years and exercisable at a price of $0.40 until October 15, 2030.
The Company has also cancelled an aggregate of 200,000 incentive stock options previously granted on October 28, 2021, pursuant to the Company’s stock option plan. Following cancellation, the holders will have no further rights or entitlements under these options.
Shares for Debt
Mr. Henry Dubina, Chief Executive Officer of the Company, has agreed to settle outstanding indebtedness owing to him in the amount of $100,000 through the issuance of 303,030 common shares at a deemed price of $0.33 per share.
The Company has also approved the issuance of common shares in settlement of a portion of directors’ fees owed to its independent directors. A total of 67,045 common shares will be issued at a deemed price of $0.33 per share, in satisfaction of $22,125 in accrued fees owing to the independent directors of the Company.
All shares issued pursuant to the shares-for-debt settlements will be subject to a statutory four-month hold period in accordance with applicable securities laws.
The issuance of common shares to directors and an officer of the Company, pursuant to the shares-fordebt settlements, is considered a related party transaction within the meaning of Multilateral Instrument 61101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company intends to rely upon exemptions from the formal valuation and minority approval requirements in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of the share issuances, as neither the fair market value of, nor the fair market value of the consideration for, the common shares exceeds twenty-five percent of the market capitalization of the Company.
About Telescope Innovations
Telescope Innovations is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.
On behalf of the Board,
Telescope Innovations Corp.
Henry Dubina, Chief Executive Officer
For additional information, please contact
Jeffrey Sherman, Ph.D. Investor Relations
E: [email protected]
Forward-looking information
The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain certain “forward-looking information” under applicable Canadian securities laws. When or if used in this news release, the words “anticipate,” “believe,” “estimate,” “expect”, “intend”, “target”, “plan,” “forecast,” “may,” “schedule,” and similar words or expressions identify forward-looking information. This forward-looking information may relate to planned project development, exploration programs, the intended use of the proceeds from the Offering and other factors or information.
Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.
The forward-looking information contained in this news release is made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
